Some benefits of FDA-approved GLP-1/GIP medications beyond weight loss are supported by emerging research and may vary based on individual health conditions, including: Improve blood sugar regulation, increase insulin sensitivity, and lower A1C Reduce long-term diabetic risks and protect pancreatic function Lower cholesterol, triglycerides, and blood pressure, supporting long-term cardiovascular health Show promising reductions in heart attacks and strokes in early studies Reduce liver fat and potentially improve metabolic fatty liver disease
Risks, Side Effects, and Regulatory Considerations Though ozone therapy shows promise for joint pain, understanding its risks is vital for patient safety
KLOW has not been approved by the FDA as a treatment, and no clinical study has established an ideal KLOW cycle
Your healthc are pro v ider should te ll yo u if you nee d t o pi nch th e s k in before injecting
Every Sunday I write these notes